Affyimmune Therapeutics, Inc., a Natick-based clinical stage biotech company specializing in solid cancer treatment, has named biotech entrepreneur and executive Robert Forrester to its board of directors.
A Sept. 22 study released by Worcester-based nonprofit Wake Up Narcolepsy has found physicians in and around Boston may know less about diagnosing narcolepsy than they think they do.
Marlborough-based medical technology company Hologic’s second annual Global Women’s Health Index reveals a lack of progress in women’s health care indicators worldwide.
The board of directors of Blue Cross Blue Shield of Massachusetts has named its first female CEO, Sarah Iselin, the Boston-based health insurer announced at the end of August.
While demand for affordable housing outstrips available units and rents continue to rise, homelessness rates in Central Massachusetts are skyrocketing.Â